Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples